Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer, Metastases

In brief

The purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine is better than capecitabine alone in shrinking or slowing the growth of the cancer in women with metastatic breast cancer who are resistant to taxane and received anthracycline chemotherapy. The safety of this treatment will also be studied.

Key facts

Study ID

NCT00080301

Run by

R-Pharm

People needed

752

Starts

2003-09-01

Expected to finish

2008-03-01

Last updated by the study team

2020-11-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Local Institution — San Francisco, California, United States
• Local Institution — Vallejo, California, United States
• Local Institution — Denver, Colorado, United States
• Local Institution — Hartford, Connecticut, United States
• Local Institution — Washington D.C., District of Columbia, United States
• Local Institution — Orlando, Florida, United States
• Local Institution — Baltimore, Maryland, United States
• Local Institution — Burlington, Massachusetts, United States
• Local Institution — Jackson, Mississippi, United States
• Local Institution — Columbia, Missouri, United States
• Local Institution — Kansas City, Missouri, United States
• Local Institution — St Louis, Missouri, United States
• Local Institution — Omaha, Nebraska, United States
• Local Institution — Livingston, New Jersey, United States
• Local Institution — New Brunswick, New Jersey, United States
• Local Institution — Albuquerque, New Mexico, United States
• Local Institution — New York, New York, United States
• Local Institution — Columbus, Ohio, United States
• Local Institution — Oklahoma City, Oklahoma, United States
• Local Institution — Tulsa, Oklahoma, United States
• Local Institution — Pittsburgh, Pennsylvania, United States
• Local Institution — Columbia, South Carolina, United States
• Local Institution — Greenville, South Carolina, United States
• Local Institution — Knoxville, Tennessee, United States
• Local Institution — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.